The present invention relates to novel substituted tetrahydro-4H-thieno-pyrrolo[3,2-c]pyridines of the general formula 1, geometrical isomers, mixtures of geometrical isomers, and pharmaceutically acceptable salts thereof,wherein:Th represents annelated thienic cycle；W represents odinary bond (in this case R3 is bound directly to N-atom of pyrrole cycle), methylene, 1,2-ethylene, 1,2-vinyl, 1,2-ethynylene, 1,3-propanediyl or 1,3-propenylene, optionally substituted with hydroxy group；R1 and R2 represent hydrogen, C1-C4alkyl, halogen or -CH2OH；R3 represents hydrogen, optionally substituted phenyl, optionally substituted azaheteroaryl；R4 represents C1-C4alkyl, CO2C2H5 or CO2C(CH3)3；R5, R6, R7 independently of each other represent hydrogen or C1-C4alkyl, orR5 and R6 form together ethylene bridge, and R7 represents hydrogen, or R5 and R7 form together ethylene bridge, and R6 represents hydrogen.And also to synthesis of novel chemical compounds, novel physiologically active compounds, "molecular tools", to pharmaceutical composition, methods for preparation thereof and to method of treatment and prophylaxis of various diseases including diseases of central nervous system (CNS).
